These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 12553422)
21. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP. Naylor HM; Newcomer ME Biochemistry; 1999 Mar; 38(9):2647-53. PubMed ID: 10052934 [TBL] [Abstract][Full Text] [Related]
22. Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative. Almeida MR; Macedo B; Cardoso I; Alves I; Valencia G; Arsequell G; Planas A; Saraiva MJ Biochem J; 2004 Jul; 381(Pt 2):351-6. PubMed ID: 15080795 [TBL] [Abstract][Full Text] [Related]
31. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Lai Z; Colón W; Kelly JW Biochemistry; 1996 May; 35(20):6470-82. PubMed ID: 8639594 [TBL] [Abstract][Full Text] [Related]
32. Hormone affinity and fibril formation of piscine transthyretin: the role of the N-terminal. Morgado I; Melo EP; Lundberg E; Estrela NL; Sauer-Eriksson AE; Power DM Mol Cell Endocrinol; 2008 Nov; 295(1-2):48-58. PubMed ID: 18620020 [TBL] [Abstract][Full Text] [Related]
33. Conformational differences between the wild type and V30M mutant transthyretin modulate its binding to genistein: implications to tetramer stability and ligand-binding. Trivella DB; Bleicher L; Palmieri Lde C; Wiggers HJ; Montanari CA; Kelly JW; Lima LM; Foguel D; Polikarpov I J Struct Biol; 2010 Jun; 170(3):522-31. PubMed ID: 20211733 [TBL] [Abstract][Full Text] [Related]
34. Clusterin regulates transthyretin amyloidosis. Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600 [TBL] [Abstract][Full Text] [Related]
35. Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosis. Jono H; Anno T; Motoyama K; Misumi Y; Tasaki M; Oshima T; Mori Y; Mizuguchi M; Ueda M; Shono M; Obayashi K; Arima H; Ando Y Biochem J; 2011 Jul; 437(1):35-42. PubMed ID: 21668413 [TBL] [Abstract][Full Text] [Related]
36. Retention of misfolded mutant transthyretin by the chaperone BiP/GRP78 mitigates amyloidogenesis. Sörgjerd K; Ghafouri B; Jonsson BH; Kelly JW; Blond SY; Hammarström P J Mol Biol; 2006 Feb; 356(2):469-82. PubMed ID: 16376939 [TBL] [Abstract][Full Text] [Related]
37. Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding. Miyata M; Sato T; Mizuguchi M; Nakamura T; Ikemizu S; Nabeshima Y; Susuki S; Suwa Y; Morioka H; Ando Y; Suico MA; Shuto T; Koga T; Yamagata Y; Kai H Biochemistry; 2010 Jan; 49(1):114-23. PubMed ID: 19950966 [TBL] [Abstract][Full Text] [Related]
38. [Transthyretin: it's miracle function and pathogenesis]. Ando Y Rinsho Byori; 2009 Mar; 57(3):228-35. PubMed ID: 19363993 [TBL] [Abstract][Full Text] [Related]
39. X-ray diffraction studies of fibrils formed from peptide fragments of transthyretin. Jarvis JA; Craik DJ; Wilce MC Biochem Biophys Res Commun; 1993 May; 192(3):991-8. PubMed ID: 8507211 [TBL] [Abstract][Full Text] [Related]
40. Structural evidence for asymmetric ligand binding to transthyretin. Cianci M; Folli C; Zonta F; Florio P; Berni R; Zanotti G Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1582-92. PubMed ID: 26249340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]